G Franchi

576 citations
32 papers · 456 indexed · h-index 11

G Franchi

30 papers receiving 404 citations

Peers

G Franchi
Comparison fields: 5 of 90
  • Pharmacology 72
  • Oncology 177
  • Cancer Research 72
  • Biotechnology 25
  • Clinical Biochemistry 18
Replace Annabel G. Liebelt with:
Annabel G. Liebelt United States
Amy C. Munthe‐Kaas Norway
Takashi Tsuruo Japan
P. Schein United States
Hironori Kawabata Japan
W. H. Fishman United States
R. Rosso Italy
Dennis M. DiSorbo United States
Maria Kehl Germany
Matthias Blumrich Germany
G Franchi relative to Annabel G. Liebelt United States Annabel G. Liebelt's profile →
Citations per field
00.5×1.5×2.5×
Annabel G. Liebelt · 1×
Citations per year

Countries citing papers authored by G Franchi

Since Specialization
Citations

This map shows the geographic impact of G Franchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Franchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Franchi more than expected).

Fields of papers citing papers by G Franchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Franchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Franchi. The network helps show where G Franchi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G Franchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G Franchi Line = papers co-authored together G Franchi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 19833
2
Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.
197812
3 19768
4
[Progress of clinical pharmacology in essential headaches].
19761
5
[Clinical pharmacology of pindolol on vasomotor receptors].
19751
6
Metabolic pathways of threonine in rat liver.
19742
7
Chemotherapy of cancer dissemination and metastasis
1973108
8 19734
9 19732
10 19733
11 19735
12 197331
13 197129
14 19701
15 197026
16
[Experimental intracranial hemorrhage. Protective action of drugs with anti-protease activity].
19691
17 19692
18 196921
19 196917
20
[A "test" for the study of the painful action of bradykinin in animals: the "cry-flight" phenomenon in the rabbit].
19662

About G Franchi

G Franchi is a scholar working on Applied Microbiology and Biotechnology, Biochemistry and Biological Psychiatry, having authored 32 papers that have together received 456 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer Cells and Metastasis (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Effects of Radiation Exposure (2 papers). The work is most often cited by research in Pharmacology (72 citations), Oncology (177 citations) and Cancer Research (72 citations). G Franchi has collaborated with scholars based in Italy and Netherlands. Frequent co-authors include Silvio Garattini, R. Rosso, M.G. Donelli, L. Morasca, Andreina Poggi, Alberto Mantovani, Annunciata Vecchi, Federico Spreafico, Paolo Ferruti and Nadia Polentarutti. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026